Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?

The New York Times – Business:

Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.

Apoorva Mandavilli
Author: Apoorva Mandavilli

This post first appeared in The New York Times – Business. Read the original article.

Written by

Apoorva Mandavilli

in

Drugs (Pharmaceuticals), Europe, Gender, Janssen Pharmaceutica, Johnson & Johnson, North America, South America, Vaccination and Immunization, Viruses
←Russian Citizen Accused of Running Cryptocurrency Exchange Used by Criminals
In Philadelphia, a Cocktail Bar With Bold Colors and Swedish Meatballs→

More posts

  • Kansas Republicans fear Roger Marshall may be running out of time

  • No One Born After 1995 Can Identify 25/38 Of These Classic Saturday Morning Cartoons From A Single Screenshot

  • Pope Leo to be discharged from the hospital after lung cancer surgery

  • Russia hits more than 15 energy sites to force blackouts in Ukraine, Zelenskyy says

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube